Nutriband Inc (NTRB)

$6.38 +0.15 (2.41%)
Market Cap 71.16M
Revenue (ttm) 2.14M
Net Income (ttm) -10.48M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -489.72%
Debt to Equity Ratio 0.01
Volume 13,300
Avg Vol 139,530
Day's Range N/A - N/A
Shares Out 11.15M
Stochastic %K 66%
Beta 1.13
Analysts Sell
Price Target $15.00

Company Profile

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company h...

Industry: Biotechnology
Sector: Healthcare
Phone: 407 377 6695
Address:
121 South Orange Avenue, Suite 1500, Orlando, United States
NetworkNewsWire
NetworkNewsWire Sep. 4 at 7:45 PM
BioMedNewsBreaks – $NTRB Secures $5.3 Million from Warrant Exercises to Advance AVERSA Fentanyl NDA https://ibn.fm/HqgzL
0 · Reply
birdmanCap
birdmanCap Sep. 3 at 9:04 PM
$NTRB warrants exercised above market price. First FDA meeting in 2 weeks. Something looking good here 👀
0 · Reply
Covode13
Covode13 Sep. 3 at 8:26 PM
$NTRB something sparking ?
0 · Reply
NNTrader
NNTrader Aug. 28 at 11:14 AM
$NTRB any news?
0 · Reply
Master47
Master47 Aug. 22 at 6:00 PM
$NTRB https://www.youtube.com/watch?v=rhM6omY2ldk
0 · Reply
VictoryWylde
VictoryWylde Aug. 22 at 1:12 PM
$NTRB anyone catch the growth conference and care to share thoughts?
5 · Reply
Covode13
Covode13 Aug. 21 at 12:36 PM
$NTRB looks like the meeting sept 18th will get us to the FDA approval quicker. At least we have movement on this.
1 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 20 at 7:14 PM
$NTRB: When Regulatory Momentum Meets Leadership Continuity https://ibn.fm/APcl0
0 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 18 at 7:50 PM
BioMedNewsBreaks – $NTRB to Present at Emerging Growth Conference on August 20 https://ibn.fm/rS3c9
1 · Reply
Covode13
Covode13 Aug. 18 at 12:53 AM
$NTRB when are they going to have FDA approval from them?
0 · Reply
Latest News on NTRB
Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000

Sep 3, 2025, 4:01 PM EDT - 3 days ago

Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000

NTRBW

Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025

Aug 18, 2025, 9:00 AM EDT - 19 days ago

Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025

Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election

Aug 11, 2025, 5:00 AM EDT - 26 days ago

Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election

NTRBW

FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Aug 8, 2025, 8:00 AM EDT - 4 weeks ago

FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

NTRBW

Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval

Jul 18, 2025, 9:15 AM EDT - 7 weeks ago

Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval

NTRBW

Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

Jul 2, 2025, 8:05 AM EDT - 2 months ago

Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

NTRBW

Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index

Jul 1, 2025, 7:00 AM EDT - 2 months ago

Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index

NTRBW

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology

Jun 9, 2025, 7:30 AM EDT - 3 months ago

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology

NTRBW

Nutriband CEO Publishes Letter to Shareholders

Apr 30, 2025, 7:30 AM EDT - 4 months ago

Nutriband CEO Publishes Letter to Shareholders

NTRBW

Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

Apr 11, 2025, 7:00 AM EDT - 5 months ago

Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

NTRBW

UPDATE – Nutriband Signs Associate Partnership with Charlotte FC

Apr 4, 2025, 5:41 PM EDT - 5 months ago

UPDATE – Nutriband Signs Associate Partnership with Charlotte FC

NTRBW

Nutriband Signs Partnership Agreement with Charlotte FC

Apr 4, 2025, 7:00 AM EDT - 5 months ago

Nutriband Signs Partnership Agreement with Charlotte FC

NTRBW

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

Feb 21, 2025, 7:00 AM EST - 7 months ago

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

NTRBW

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Feb 13, 2025, 7:00 AM EST - 7 months ago

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

NTRBW

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

Feb 7, 2025, 8:45 AM EST - 7 months ago

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

NTRBW

Nutriband Issues Letter to Shareholders

Dec 31, 2024, 7:00 AM EST - 8 months ago

Nutriband Issues Letter to Shareholders

NTRBW

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

Dec 27, 2024, 9:25 AM EST - 9 months ago

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

NTRBW

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Dec 4, 2024, 9:00 AM EST - 9 months ago

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

NTRBW

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

Nov 27, 2024, 7:00 AM EST - 10 months ago

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

NTRBW

Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application

Oct 31, 2024, 8:35 AM EDT - 11 months ago

Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application

NTRBW

Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica

Oct 17, 2024, 7:00 AM EDT - 11 months ago

Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica

NTRBW

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17

Oct 2, 2024, 7:00 AM EDT - 1 year ago

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17

NTRBW

Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology

Sep 24, 2024, 7:00 AM EDT - 1 year ago

Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology

NTRBW

Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch

Sep 20, 2024, 6:50 AM EDT - 1 year ago

Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch

NTRBW

Nutriband Inc. Authorizes $1M Share Buyback Program

Sep 16, 2024, 4:00 PM EDT - 1 year ago

Nutriband Inc. Authorizes $1M Share Buyback Program

NTRBW

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Sep 4, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

NTRBW

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25

Jul 19, 2024, 7:00 AM EDT - 1 year ago

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25

NTRBW

Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology

Jul 15, 2024, 7:00 AM EDT - 1 year ago

Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology

NTRBW

Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl

Jun 20, 2024, 7:00 AM EDT - 1 year ago

Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl

NTRBW

Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year

Jun 3, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year

NTRBW

Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors

May 16, 2024, 7:00 AM EDT - 1 year ago

Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors

NTRBW

Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

May 10, 2024, 9:00 AM EDT - 1 year ago

Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

CANF

Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group

Apr 23, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group

NTRBW

Nutriband Inc. Announces $8.4M Private Placement

Apr 19, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc. Announces $8.4M Private Placement

NTRBW

Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting

Mar 25, 2024, 7:00 AM EDT - 1 year ago

Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting

NTRBW

Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting

Mar 4, 2024, 7:00 AM EST - 1 year ago

Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting

NTRBW

Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st

Jan 29, 2024, 7:00 AM EST - 1 year ago

Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st

NTRBW

Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling

Nov 28, 2023, 7:00 AM EST - 1 year ago

Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling

NTRBW

Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape

Nov 8, 2023, 7:00 AM EST - 1 year ago

Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape

NTRBW

Nutriband's Aversa(TM) Buprenoprhine May Reach Peak Annual Sales of $70-130 Million Based on Market Assessment by Leading Healthcare Consulting Firm

Oct 11, 2023, 7:42 AM EDT - 2 years ago

Nutriband's Aversa(TM) Buprenoprhine May Reach Peak Annual Sales of $70-130 Million Based on Market Assessment by Leading Healthcare Consulting Firm

NTRBW

Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology

Sep 20, 2023, 7:30 AM EDT - 2 years ago

Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology

NTRBW

Nutriband Inc. Receives Five Nominations in the Pharma Industry Awards 2023

Sep 12, 2023, 7:00 AM EDT - 2 years ago

Nutriband Inc. Receives Five Nominations in the Pharma Industry Awards 2023

Nutriband Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update

Sep 11, 2023, 7:00 AM EDT - 2 years ago

Nutriband Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update

NTRBW

Nutriband Inc. Announces Donovan McNabb as AI Tape Brand Ambassador

Aug 30, 2023, 8:00 AM EDT - 2 years ago

Nutriband Inc. Announces Donovan McNabb as AI Tape Brand Ambassador

NTRBW

Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings

Jul 27, 2023, 8:30 AM EDT - 2 years ago

Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings

NTRBW

Nutriband Increases Existing Credit Line to $5 Million USD for the Development of its AVERSA(TM) Platform Towards FDA Submission

Jul 14, 2023, 9:20 AM EDT - 2 years ago

Nutriband Increases Existing Credit Line to $5 Million USD for the Development of its AVERSA(TM) Platform Towards FDA Submission

NTRBW

Nutriband Receives Notice of Allowance for U.S. Patent Covering Transdermal Abuse Deterrent Technology

Jun 23, 2023, 7:00 AM EDT - 2 years ago

Nutriband Receives Notice of Allowance for U.S. Patent Covering Transdermal Abuse Deterrent Technology

NTRBW

Nutriband to Attend 2023 BIO International Convention

May 10, 2023, 8:00 AM EDT - 2 years ago

Nutriband to Attend 2023 BIO International Convention

NTRBW

Nutriband Inc. Reports Revenue Up 46% in Fiscal 2023

Apr 27, 2023, 8:00 AM EDT - 2 years ago

Nutriband Inc. Reports Revenue Up 46% in Fiscal 2023

NTRBW

Nutriband Inc. to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023

Apr 19, 2023, 7:00 AM EDT - 2 years ago

Nutriband Inc. to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023

NTRBW

NetworkNewsWire
NetworkNewsWire Sep. 4 at 7:45 PM
BioMedNewsBreaks – $NTRB Secures $5.3 Million from Warrant Exercises to Advance AVERSA Fentanyl NDA https://ibn.fm/HqgzL
0 · Reply
birdmanCap
birdmanCap Sep. 3 at 9:04 PM
$NTRB warrants exercised above market price. First FDA meeting in 2 weeks. Something looking good here 👀
0 · Reply
Covode13
Covode13 Sep. 3 at 8:26 PM
$NTRB something sparking ?
0 · Reply
NNTrader
NNTrader Aug. 28 at 11:14 AM
$NTRB any news?
0 · Reply
Master47
Master47 Aug. 22 at 6:00 PM
$NTRB https://www.youtube.com/watch?v=rhM6omY2ldk
0 · Reply
VictoryWylde
VictoryWylde Aug. 22 at 1:12 PM
$NTRB anyone catch the growth conference and care to share thoughts?
5 · Reply
Covode13
Covode13 Aug. 21 at 12:36 PM
$NTRB looks like the meeting sept 18th will get us to the FDA approval quicker. At least we have movement on this.
1 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 20 at 7:14 PM
$NTRB: When Regulatory Momentum Meets Leadership Continuity https://ibn.fm/APcl0
0 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 18 at 7:50 PM
BioMedNewsBreaks – $NTRB to Present at Emerging Growth Conference on August 20 https://ibn.fm/rS3c9
1 · Reply
Covode13
Covode13 Aug. 18 at 12:53 AM
$NTRB when are they going to have FDA approval from them?
0 · Reply
BullInvest
BullInvest Aug. 14 at 9:05 PM
$NTRB I wonder if this drop has to Do with Sheridan leaving the ceo chair. I mean, no bad news, everything still on track. I’m buying more down here. This is easily $20 a share when FDA approves. Unless I’m missing something
0 · Reply
Covode13
Covode13 Aug. 14 at 6:08 PM
$NTRB wtf
0 · Reply
NNTrader
NNTrader Aug. 14 at 4:31 PM
$NTRB disappointing
0 · Reply
JhonHack
JhonHack Aug. 13 at 5:32 PM
$NTRB Sheridan may have just given everyone a worthless gift before riding off into the sunset. At best he doesn’t seem to expect FDA advances in the next 90 days. “May come back if not elected” is not what we wanted to hear chief.
2 · Reply
SOuL_Builder
SOuL_Builder Aug. 12 at 5:59 PM
$NTRB anyone know when we can trade NTRBWB into cash?
2 · Reply
Channelchek
Channelchek Aug. 12 at 1:58 PM
Noble Capital Markets Research Report: Nutriband ($NTRB) – CEO Gareth Sheridan To Run For President Of Ireland CFO Will Transition To CEO. Nutriband CEO and Co-Founder Gareth Sheridan has announced plans to take a three-month leave from the company to run for President of the Republic of Ireland. The current CFO and Co-Founder, Serguei Melnik, will become Acting CEO as Mr. Sheridan campaigns. The election is expected to be held in late September or early October. If elected, Sergeui will become CEO. If Mr. Sheridan is not elected, he may return to the company. Read more: https://www.channelchek.com/news-channel/nutriband-ntrb-ceo-gareth-sheridan-to-run-for-president-of-ireland
0 · Reply
Covode13
Covode13 Aug. 11 at 10:57 PM
$NTRB why would he leave right before the company is going to get a FDA approval?
2 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 11 at 7:35 PM
InvestorNewsBreaks – $NTRB CEO Steps Aside Temporarily to Run for Irish Presidency https://ibn.fm/UONkK
0 · Reply
gnarled15
gnarled15 Aug. 11 at 1:23 PM
$NTRB 🤦‍♂️ bizzarro world
0 · Reply
Dollaraire
Dollaraire Aug. 11 at 11:18 AM
$NTRB Nobody want this
0 · Reply
douglas98
douglas98 Aug. 10 at 5:32 PM
$NTRB Sheridan has a very slim chance of being nominated for the presidency and absolutely zero chance of winning. Strange move
1 · Reply
BullInvest
BullInvest Aug. 10 at 3:09 PM
$NTRB so Gareth stepped down as a CEO to run for president in Ireland? Who is going to take his position?
1 · Reply